Can a cancer antigen (CA)15-3 directed monitoring strategy be resource sparing in metastatic breast cancer (MBC)?

被引：0
|
作者：
Chakraborty, Santam [1 ]
Nallathambi, Chandran [1 ]
Chakraborty, Subhosmito [1 ]
Ghatak, Ishita [1 ]
Ganguly, Sandip [1 ]
Ghosh, Joydeep [1 ]
Ahmed, Rosina [1 ]
Agrawal, Sanjit [1 ]
Chatterjee, Sanjoy [1 ]
机构：
[1] Tata Med Ctr, Kolkata, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13104
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CA 15-3 elevations according to breast cancer subtypes at initial diagnosis of metastatic breast cancer (MBC)
    Park, S.
    Ahn, H. K.
    Lim, T.
    Park, Y. H.
    Ahn, J. S.
    Im, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Evaluation of the benefit of the tumor marker cancer antigen 15-3 (CA 15-3) in different subtypes of metastatic breast cancer
    Lindman, Henrik
    Molin, Ebba Cederqvist
    Jernling, Martin
    Schiza, Aglia
    CANCER RESEARCH, 2023, 83 (05)
  • [3] CA 15-3 kinetics: clinical implication of CA 15-3 surge in metastatic breast cancer
    Park, Yeon Hee
    Kim, Hyo Song
    Ahn, Jin Seok
    Im, Young-Hyuck
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 881 - 882
  • [4] Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients
    Einarsson, R
    Lindman, H
    Bergh, J
    ANTICANCER RESEARCH, 2000, 20 (6D) : 5089 - 5093
  • [5] Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
    Shih-Chung Wu
    Fong-Fu Chou
    Kun-Ming Rau
    Breast Cancer Research and Treatment, 2010, 124 : 879 - 882
  • [6] Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
    Hing, J. X.
    Mok, C. W.
    Tan, P. T.
    Sudhakar, S. S.
    Seah, C. M.
    Lee, W. P.
    Tan, S. M.
    BREAST, 2020, 52 : 95 - 101
  • [7] Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer
    Wu, Shih-Chung
    Chou, Fong-Fu
    Rau, Kun-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 879 - 880
  • [8] CA 15-3 IN BREAST-CANCER
    ANTOINE, E
    KAYITALIRE, L
    SPIELMANN, M
    REVUE DE MEDECINE INTERNE, 1994, 15 (10): : 650 - 662
  • [9] Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer
    Findeisen, R
    Albrecht, S
    Richter, B
    Deutschmann, K
    Distler, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (11) : 841 - 846
  • [10] Comparison of Serum Ferritin with Carbohydrate Antigen 15-3 (CA 15-3) in Breast Cancer patients in Pakistan
    Mahmood, Maira
    Haq, Muhammad Fahimul
    Nizami, Naim Ahmad
    Akram, Shuma
    Choudhry, Nakhshab
    Yasmin, Riffat
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2016, 10 (04): : 1384 - 1389
12345